Blue Owl Capital Completes Acquisition of Sila Realty Trust
On July 1, 2026, Blue Owl Capital Inc. announced a significant milestone in its investment strategy by successfully completing its acquisition of Sila Realty Trust, Inc. (NYSE: Sila), a net lease real estate investment trust (REIT) focused on the thriving healthcare sector. The transaction not only marks an expansion of Blue Owl's portfolio but also reflects the firm’s commitment to investing in essential real estate sectors with solid growth potential.
The Acquisition Details
Sila Realty Trust has been recognized for its diversified portfolio, which includes high-quality healthcare assets that are leased to strong tenants on well-structured long-term agreements. Marc Zahr, Co-President and Global Head of Real Assets at Blue Owl, emphasized that integrating Sila into Blue Owl's Real Assets platform will enhance their core net lease strategy. He stated, “This acquisition allows us to capitalize on the increasing demand for healthcare facilities even as the industry experiences rapid growth.”
The acquisition highlights Blue Owl’s approach to identifying investment opportunities that provide strong returns while also supporting the communities that rely on these healthcare facilities. The company is optimistic that this strategic acquisition will bolster its focus on delivering enduring value to its investors and stakeholders.
On June 26, 2026, at Sila’s Special Meeting of Stockholders, an overwhelming 98% approved the merger agreement, demonstrating strong support from Sila's shareholders. Following the close of the deal, Sila's common stock was delisted from the New York Stock Exchange, with shareholders receiving $30.38 per share—reflecting a significant 19% premium over its last closing price prior to the announcement.
Strategic Benefits and Market Impact
The completion of this acquisition is seen as an important step in Blue Owl's expansion strategy across fundamental real estate sectors. The inclusion of Sila’s healthcare assets enhances Blue Owl's already solid foundation, leveraging the firm’s institutional expertise, diverse resources, and established relationships in the real estate market.
This move aligns with broader trends in the healthcare sector, where demand for high-quality facilities is expected to grow in light of demographic shifts and evolving healthcare delivery models. Investing in healthcare real estate has increasingly become appealing to institutional investors looking for stable, long-term returns.
Blue Owl, as of March 31, 2026, manages approximately $315 billion in assets across various alternative investment strategies, which speaks volumes about its significant market presence and operational capabilities. The firm operates through three primary platforms—Credit, Real Assets, and GP Strategic Capital—providing a diverse range of investment opportunities aimed at facilitating long-term growth.
Future Outlook
As Blue Owl Capital prepares to integrate the Sila portfolio into its operations, the firm's management expressed confidence in capitalizing on the health sector's strong fundamentals. The strategic acquisition not only strengthens Blue Owl's portfolio but also expands its capacity to deliver substantial value over the long term.
Looking ahead, Blue Owl aims to continue identifying quality investment opportunities across the real estate landscape, maintaining a focus on delivering compelling returns for its investors while contributing to the stability and growth of the sectors in which it operates. This acquisition exemplifies Blue Owl’s innovative approach to harnessing the potential of niche markets such as healthcare real estate, setting the stage for sustained success.
For more information about Blue Owl Capital and its investment strategies, visit
Blue Owl's official website.